Stock 2276 SHANGHAI CONANT OPTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shanghai Conant Optical Co., Ltd.

Equities

2276

CNE100004Z14

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:11 2024-05-08 am EDT 		5-day change 1st Jan Change
8.74 HKD -1.91% Intraday chart for Shanghai Conant Optical Co., Ltd. -4.48% +23.80%
Mar. 27 Shanghai Conant Optical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 05 Shanghai Conant Optical Co., Ltd. Announces Change of Address of Principal Place of Business in Hong Kong CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 1,557 1,778 2,737 3,507 - -
Enterprise Value (EV) 1 1,557 1,778 2,737 3,507 3,507 3,507
P/E ratio 6.19 x 7.19 x 8.33 x 8.37 x 7.45 x 6.37 x
Yield - - - 2.85% 3.37% -
Capitalization / Revenue - - 1.56 x 1.72 x 1.51 x 1.35 x
EV / Revenue - - 1.56 x 1.72 x 1.51 x 1.35 x
EV / EBITDA - - - - - -
EV / FCF - - - 13.5 x 13.4 x -
FCF Yield - - - 7.39% 7.44% -
Price to Book - - - 2.04 x 1.7 x 1.41 x
Nbr of stocks (in thousands) 426,600 426,600 426,600 426,600 - -
Reference price 2 3.650 4.169 6.417 8.221 8.221 8.221
Announcement Date 3/25/22 3/17/23 3/27/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - - 1,760 2,039 2,321 2,591
EBITDA - - - - - -
EBIT 1 - - 380 501 551.5 -
Operating Margin - - 21.59% 24.57% 23.76% -
Earnings before Tax (EBT) 1 - - 393 489.5 576.5 610
Net income 1 183.5 248.6 327 418.2 470.8 550
Net margin - - 18.58% 20.52% 20.28% 21.22%
EPS 2 0.5900 0.5800 0.7700 0.9820 1.103 1.290
Free Cash Flow 1 - - - 259 261 -
FCF margin - - - 12.7% 11.24% -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - 61.92% 55.44% -
Dividend per Share 2 - - - 0.2345 0.2770 -
Announcement Date 3/25/22 3/17/23 3/27/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - - - 259 261 -
ROE (net income / shareholders' equity) - - - 24.4% 23.3% 21%
ROA (Net income/ Total Assets) - - - 17.7% 17.5% -
Assets 1 - - - 2,363 2,698 -
Book Value Per Share 2 - - - 4.030 4.830 5.830
Cash Flow per Share 2 - - - 0.8500 0.9600 1.070
Capex 1 - - - 100 115 93
Capex / Sales - - - 4.91% 4.94% 3.59%
Announcement Date 3/25/22 3/17/23 3/27/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8.221 CNY
Average target price
12.32 CNY
Spread / Average Target
+49.92%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

1st Jan change Capi.
SHANGHAI CONANT OPTICAL CO., LTD. Stock Shanghai Conant Optical Co., Ltd.
+23.80% 486M
ESSILORLUXOTTICA Stock EssilorLuxottica
+13.05% 99.81B
ALCON INC. Stock Alcon Inc.
+11.61% 39.88B
THE COOPER COMPANIES, INC. Stock The Cooper Companies, Inc.
-1.26% 18.57B
AUTEK CHINA INC. Stock Autek China Inc.
-13.68% 2.42B
WARBY PARKER INC. Stock Warby Parker Inc.
-10.21% 1.5B
PEGAVISION CORPORATION Stock Pegavision Corporation
+24.72% 1.19B
MINGYUE OPTICAL LENS CO.,LTD. Stock Mingyue Optical Lens Co.,Ltd.
-33.16% 778M
MENICON CO., LTD. Stock Menicon Co., Ltd.
-35.31% 752M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Stock Universal Vision Biotechnology Co., Ltd.
-7.40% 671M
Glasses, Spectacles & Contact Lenses
  1. Stock Market
  2. Equities
  3. 2276 Stock
  4. Financials Shanghai Conant Optical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW